GS-US-540-5807 [COVID-19]
Research type
Research Study
Full title
A Multi-center, Multi-country Retrospective Cohort Study to Evaluate the Clinical Outcomes in Adults with Severe COVID-19
IRAS ID
282652
Contact name
Anton Pozniak
Contact email
Sponsor organisation
Gilead Sciences, Inc.
Duration of Study in the UK
0 years, 0 months, 24 days
Research summary
This is a multi-center, multi-country retrospective cohort study. Up to 2000 severe COVID-19 cases across up to 50 participating study sites who meet all eligibility criteria will be included in the analysis. Deidentified data will be extracted from electronic medical record (EMR) databases, clinical registries, case series or additional sources from participating sites and countries, and then entered into a structured e-CRF system (or transferred electronically if feasible), then pooled into\none database with standard data format. This real-world standard of care (SOC) cohort can be used to assess efficacy comparisons to potential future treatments. In addition, each site/country will be surveyed to determine the local standard of care therapy for COVID-19 infection.
REC name
N/A
REC reference
N/A